4/A

FORM 4/A SUBMISSION

Company: Aldeyra Therapeutics, Inc.
Filed: March 6, 2020
Period of Report: March 2, 2020
Accession Number: 0000899243-20-007448

View Document ↗ View on SEC.gov ↗